CY1111165T1 - Μειγματα ολιγοσακχαριτων που προερχονται απο την ηπαρινη, η παρασκευη τους και οι φαρμακευτικες ενωσεις που τα περιεχουν - Google Patents

Μειγματα ολιγοσακχαριτων που προερχονται απο την ηπαρινη, η παρασκευη τους και οι φαρμακευτικες ενωσεις που τα περιεχουν

Info

Publication number
CY1111165T1
CY1111165T1 CY20111100132T CY111100132T CY1111165T1 CY 1111165 T1 CY1111165 T1 CY 1111165T1 CY 20111100132 T CY20111100132 T CY 20111100132T CY 111100132 T CY111100132 T CY 111100132T CY 1111165 T1 CY1111165 T1 CY 1111165T1
Authority
CY
Cyprus
Prior art keywords
compounds containing
pharmaceutical compounds
usrin
oligosachars
mixes
Prior art date
Application number
CY20111100132T
Other languages
Greek (el)
English (en)
Inventor
Volker Laux
Pierre Mourier
Christian Viskov
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of CY1111165T1 publication Critical patent/CY1111165T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY20111100132T 2003-07-24 2011-02-04 Μειγματα ολιγοσακχαριτων που προερχονται απο την ηπαρινη, η παρασκευη τους και οι φαρμακευτικες ενωσεις που τα περιεχουν CY1111165T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0309041A FR2857971B1 (fr) 2003-07-24 2003-07-24 Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP04785991A EP1651677B1 (fr) 2003-07-24 2004-07-22 Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
CY1111165T1 true CY1111165T1 (el) 2015-06-11

Family

ID=33561051

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100132T CY1111165T1 (el) 2003-07-24 2011-02-04 Μειγματα ολιγοσακχαριτων που προερχονται απο την ηπαρινη, η παρασκευη τους και οι φαρμακευτικες ενωσεις που τα περιεχουν

Country Status (39)

Country Link
EP (1) EP1651677B1 (enExample)
JP (1) JP4865552B2 (enExample)
KR (1) KR101125517B1 (enExample)
CN (1) CN1852926B (enExample)
AR (1) AR045917A1 (enExample)
AT (1) ATE487741T1 (enExample)
AU (1) AU2004259111B2 (enExample)
BR (1) BRPI0412850A (enExample)
CA (1) CA2533555A1 (enExample)
CR (1) CR8201A (enExample)
CY (1) CY1111165T1 (enExample)
DE (1) DE602004030015D1 (enExample)
DK (1) DK1651677T3 (enExample)
EC (1) ECSP066305A (enExample)
ES (1) ES2355827T3 (enExample)
FR (1) FR2857971B1 (enExample)
GT (1) GT200400145A (enExample)
HN (1) HN2004000250A (enExample)
IL (1) IL173206A (enExample)
MA (1) MA27928A1 (enExample)
ME (1) MEP11608A (enExample)
MX (1) MXPA06000336A (enExample)
MY (1) MY136769A (enExample)
NO (1) NO20060821L (enExample)
NZ (1) NZ544717A (enExample)
OA (1) OA13197A (enExample)
PA (1) PA8606801A1 (enExample)
PE (1) PE20050246A1 (enExample)
PL (1) PL1651677T3 (enExample)
PT (1) PT1651677E (enExample)
RS (1) RS20060044A (enExample)
RU (1) RU2346005C2 (enExample)
SI (1) SI1651677T1 (enExample)
TN (1) TNSN06025A1 (enExample)
TW (1) TWI369208B (enExample)
UA (1) UA89356C2 (enExample)
UY (1) UY28435A1 (enExample)
WO (1) WO2005010051A2 (enExample)
ZA (1) ZA200600657B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7589145B2 (en) 2004-04-15 2009-09-15 Exxonmobil Chemical Patents Inc. Syndiotactic rich polyolefins
EP2447285A3 (en) * 2006-05-25 2013-01-16 Momenta Pharmaceuticals, Inc. Low molecular weight heparin composition and uses thereof
CN101711771B (zh) * 2008-10-07 2015-12-09 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制法和药物组合物
DK3144325T3 (da) * 2010-09-14 2021-01-25 Univ Miyazaki Heparin med høj renhed og fremstillingsfremgangsmåde dertil
WO2012072799A1 (en) 2010-12-02 2012-06-07 Aventis Pharma S.A. New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample
CN102558392A (zh) * 2010-12-14 2012-07-11 王芃 一种高抗FXa、低抗FIIa低分子肝素钠的制备方法
CN102816255B (zh) * 2011-06-10 2015-11-25 王芃 一种超低分子肝素钠的制备方法
EP2980103B1 (en) 2013-03-26 2020-11-04 Jiuzhitang Co., Ltd. Low molecular weight glycosaminoglycan derivative, pharmaceutical composition thereof, preparation method therefor and use thereof
CN103864959A (zh) * 2014-04-03 2014-06-18 中国药科大学 一种肝素十二糖抗动脉粥样硬化的用途
RU2639574C2 (ru) * 2016-05-23 2017-12-21 Алексей Георгиевич Александров Способ получения низкомолекулярного гепарина

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2504928A1 (fr) * 1981-04-29 1982-11-05 Choay Sa Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
IT1284143B1 (it) * 1996-09-06 1998-05-08 Istituto Scient Di Chimica E B Eparansolfati semi-sintetici ad elevata attivita' antimetastica e ridotto rischio emorragico
AU7753898A (en) * 1997-06-06 1998-12-21 Hamilton Civic Hospitals Research Development, Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
FR2800074B1 (fr) * 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
FR2807043B1 (fr) * 2000-03-28 2002-11-22 Aventis Pharma Sa Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2811992B1 (fr) * 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
CA2458852A1 (en) * 2001-08-28 2003-03-06 Leo Pharma A/S Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP1651677A2 (fr) 2006-05-03
MXPA06000336A (es) 2006-03-30
TW200522970A (en) 2005-07-16
KR20060059974A (ko) 2006-06-02
JP2006528614A (ja) 2006-12-21
IL173206A (en) 2010-11-30
PE20050246A1 (es) 2005-06-02
NZ544717A (en) 2009-09-25
SI1651677T1 (sl) 2011-03-31
GT200400145A (es) 2005-03-16
AU2004259111A1 (en) 2005-02-03
AR045917A1 (es) 2005-11-16
RU2006105384A (ru) 2007-09-10
UA89356C2 (ru) 2010-01-25
CN1852926A (zh) 2006-10-25
ES2355827T3 (es) 2011-03-31
DE602004030015D1 (de) 2010-12-23
CN1852926B (zh) 2010-05-12
WO2005010051A3 (fr) 2005-06-16
PT1651677E (pt) 2011-02-08
ATE487741T1 (de) 2010-11-15
AU2004259111B2 (en) 2009-06-11
KR101125517B1 (ko) 2012-03-23
ECSP066305A (es) 2006-07-28
IL173206A0 (en) 2006-06-11
ZA200600657B (en) 2007-05-30
PA8606801A1 (es) 2005-02-04
DK1651677T3 (da) 2011-02-28
RU2346005C2 (ru) 2009-02-10
CR8201A (es) 2006-09-22
MEP11608A (en) 2010-06-10
JP4865552B2 (ja) 2012-02-01
BRPI0412850A (pt) 2006-10-03
WO2005010051A2 (fr) 2005-02-03
TNSN06025A1 (en) 2007-10-03
PL1651677T3 (pl) 2011-04-29
TWI369208B (en) 2012-08-01
FR2857971B1 (fr) 2005-08-26
CA2533555A1 (fr) 2005-02-03
NO20060821L (no) 2006-04-20
HK1094806A1 (zh) 2007-04-13
RS20060044A (sr) 2008-06-05
EP1651677B1 (fr) 2010-11-10
MA27928A1 (fr) 2006-06-01
UY28435A1 (es) 2005-02-28
HN2004000250A (es) 2006-06-29
OA13197A (fr) 2006-12-13
MY136769A (en) 2008-11-28
FR2857971A1 (fr) 2005-01-28

Similar Documents

Publication Publication Date Title
CY1111165T1 (el) Μειγματα ολιγοσακχαριτων που προερχονται απο την ηπαρινη, η παρασκευη τους και οι φαρμακευτικες ενωσεις που τα περιεχουν
CY1110774T1 (el) Μειγματα πολυσακχαριτων που προερχονται απο την ηπαρινη, η παρασκευη τους και οι φαρμακευτικες ενωσεις που τα περιεχουν
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
CY1110738T1 (el) Παραγωγα aminoαλκυλβενζοϋλ-βενζοφουραν ή βενζοθειοφαιν, μεθοδος παρασκευης τους και συνθεσεις που τα περιεχουν
BR0316915A (pt) Composição de manocompósito, método para prepará-lo e seu uso
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
CY1106032T1 (el) Υποκατασταθεισες πυραζολες
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
CY1115526T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει πιμοβενδανη
CY1108529T1 (el) Νεα αζαδικυκλικα παραγωγα, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τα περιεχουν
CY1110318T1 (el) Παραγωγα φαινοξυοξικου οξεος
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
ATE468317T1 (de) Herstellung von 1,3-diphenylprop-2-en-1- onderivaten
MY142376A (en) Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
PT1098893E (pt) Composto ciclicos uteis n tratamento da dislipidemia, aterosclerose e diabetes, composicoes farmaceuticas e processo de preparacao
CY1105387T1 (el) Υποκατεστημενα παραγωγα 2-διαλκυλαμινοαλκυλοδιφαινθλιου
GB0310919D0 (en) Pharmaceutical compositions
DE59909607D1 (de) Tan-1057 derivate
CY1109496T1 (el) Τρυγικο και φωσφορικο αλας της 3,4-διαμινοπυριδινης, φαρμακευτικες συνθεσεις και χρησεις αυτων
DE69910031D1 (de) Verfahren zur herstellung von hydroxy-25-ene vitamin d verbindungen
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
DE60019636D1 (de) Vernetzte copolymere auf der basis von nicht vernetzten polycarbonsäurepolymeren
CY1105550T1 (el) Μεμνο-πεπτιδια, μια διαδικασια για την παρασκευη και τη χρηση τους